Navigation Links
Testes stem cell can change into other body tissues, Stanford/UCSF study shows
Date:1/5/2009

STANFORD, Calif. Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes. The cells bear a striking resemblance to embryonic stem cells they can differentiate into each of the three main types of tissues of the body but the researchers caution against viewing them as one and the same.

According to the study, the testes stem cells have different patterns of gene expression and regulation and they do not proliferate and differentiate as aggressively as human embryonic stem cells.

The findings, published in the January issue of the journal Stem Cells, are in contrast to those reported in a recent Nature paper, which concluded that the cells were, in fact, as pluripotent as embryonic stem cells. Pluripotent cells can become any cell in the body and form tumors called teratomas when transplanted into mice.

"It's time to reinterpret the data," said Renee Reijo-Pera, PhD, professor of obstetrics & gynecology at Stanford, "and to accept that we're beginning to discover many different types of stem cells. Although they are all related to each other, they also all have unique therapeutic applications in which they surpass other family members."

Reijo-Pera, who is the director of Stanford's Center for Human Embryonic Stem Cell Research and Education, collaborated with male infertility specialist Paul Turek, MD, a professor of urology at UCSF and the director of The Turek Clinic in San Francisco, to conduct the research. Reijo-Pera and Turek are co-senior authors of the study.

The stem cells from the testes seem to hover in a gray area between true pluripotency and the more limited, tissue-specific multipotency exhibited by many types of adult stem cells. They termed the cells "multipotent germline stem cells." Germ cells are those cells in the body that differentiate to make sperm and eggs.

Playing to these cells' strengths in this case, their likely ability to differentiate into cells involved in male reproduction may be a wiser choice than trying to pigeonhole them as embryonic-stem-cell-wannabes, said Reijo-Pera.

"These cells could potentially treat infertility or other diseases in men," Turek said.

But the lure of pluripotency is strong. An easily accessible source of unmodified, pluripotent human cells would allow physicians and researchers to create cell lines and tissues identical to others in the donor's body. Theoretically such cells could be used as a perfectly matched therapy for that particular donor perhaps to generate new cartilage to repair a knee injury or new neurons to treat nerve damage. Alternatively, the technique could be used to derive cell lines carrying specific disease-causing mutations from a man with Parkinson's, for exampleon which to conduct research.

Coaxing specialized, or differentiated, adult cells to regress back into a more malleable, embryonic-stem-cell-like state (a process called "induced pluripotency") would also allow scientists to realize the therapeutic benefits of embryonic cells without the thorny ethical problems that plague cells derived from embryos. Until recently, however, the reprogramming of differentiated cells required the use of viruses to introduce specific genes into the cells, which may limit their therapeutic usefulness.

The researchers used cells obtained via biopsies conducted to diagnose male infertility in 19 of the clinic's patients. Each patient's cells were cultured in a manner similar to human embryonic stem cells; two of the 19 samples yielded cell lines with many characteristics of the pluripotent cells. One of the two patients from whom the cell lines were derived withdrew from the study and his samples were discarded.

Further study on the remaining cell line indicated that it expressed many, but not all, genes associated with pluripotency. The cells could also be induced to differentiate into decidedly non-testicular neural cell precursors and they expressed the telomerase enzyme essential to keep pluripotent cells young and unspecialized. However, when the researchers examined the cells' patterns of methylation a modification to DNA that affects gene expression they found that the newly derived cell line was less-thoroughly methylated as compared to human embryonic stem cells in one region and more heavily methylated than human embryonic stem cells in another region.

Finally, when the researchers injected the human stem cells into mice with compromised immune systems, they showed only a limited ability to form a teratoma a kind of tumor formed of many cell types. Teratoma formation resulting from the aggressive proliferation and differentiation of transplanted stem cells is a hallmark of true pluripotency. Together, the results suggest that the stem cells isolated from male testes have some, but not all the characteristics of true pluripotent cells.

"It's not yet possible to completely re-create human embryonic stem cells from germline cells," said Reijo-Pera, "These cells differ in gene expression, methylation and in their ability to form teratomas. But it's the fact that they are different that makes them so interesting. Suggesting otherwise would do a disservice to the research community by overlooking the fact that these cells are a unique cell type that could be really useful in the study of human germ cell formation."


'/>"/>

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center
Source:Eurekalert

Related medicine news :

1. Researchers Create Embryonic-Like Stem Cells From Human Testes
2. Stem Cells From Testes Produce Wide Range of Tissue Types
3. Stem cells derived from adult testes produce wide range of tissue types
4. Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration
5. Cardium Reports on Exchange Listing With NYSE Alternext US
6. Climate Change May Boost Contact With Pollutants
7. Rules Change Could Increase Hospice Use
8. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
9. Dynatronics Announces Changes to Board and Launches Operational Improvement Process
10. Response Biomedical Corporation Announces Change of Executives
11. White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... Los Angeles, California (PRWEB) , ... May 26, 2017 , ... ... Canadian senior citizens who visit a doctor for colds or respiratory issues that are ... note that excessive time pressure on doctors may be largely responsible for the problem ...
(Date:5/27/2017)... Rosa, CA (PRWEB) , ... May 27, 2017 , ... ... cause for concern, but a new study from the Osteoarthritis Initiative shows ... to developing knee osteoarthritis. Knowing this in advance may give doctors the opportunity to ...
(Date:5/26/2017)... Fairfax, VA (PRWEB) , ... May 26, 2017 ... ... is pleased to announce a new educational seminar to focus on current legislative ... Regulatory News(LEARN) seminar will begin at 1 p.m. Sunday, Sept. 10, and will ...
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/4/2017)... Tenn. , May 4, 2017  A ... Infection Control, Ultraviolet-C light as a ... Tru-D SmartUVC,s ability to reduce bioburden on anesthesia ... bioburden reduction on high-touch, complex medical equipment surfaces ... surgical infections. "This study further validates ...
(Date:5/4/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... announced that the Company,s first quarter 2017 financial results ... 11, 2017, and that the Company will host a ... that afternoon. Management will provide an overview of the ...
Breaking Medicine Technology: